RETAIL data specialist NostraData has just released its Informacy Portal, an intervention tool designed to mitigate the negative impact of the double dispensing policy and enhance prescription loyalty for partner pharmacies.
This follows on from the company's 60DD impact analysis which revealed that "the median prescription loyalty in Australia currently stands at just 36%, indicating a substantial opportunity".
NostraData explained that "leveraging the insights provided by the Informacy Portal, pharmacies can identify areas for improvement and use strategies to increase prescription loyalty".
"For example, an average-sized pharmacy processing 140 scripts per day increases its prescription loyalty by just 1%, and this can increase script revenue by $38,000."
NostraData pharmacist Nick Biggs emphasised the importance of practical interventions in reducing the impact of increasing dispensing quantities.
"Having made the double dispense reporting and dashboard available free to all pharmacies, we understand that pharmacists are now looking for practical interventions to offset the impact.
"This is why we have developed a prescription loyalty solution for our partner pharmacies.
"We will continue to listen to our partner pharmacies and provide additional tools to support," he said.
"NostraData is committed to empowering Australian pharmacies through the Informacy Portal.
"It serves as a vital tool to understand profit impact, assist in health service delivery to drive health outcomes, and grow prescription loyalty and adherence," Biggs said.
Partner pharmacies who have not yet accessed the portal can do so HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jul 23
